Timings of the ongoing debating schedules and milestones for the statutory instrument (SI) regulating the pre-market phase of medical devices used in Great Britain have been revised. A new roadmap updates the January 2024 series of target dates.
Great Britain Pre-Market Device Regulations Reset For Late 2025
Agency To Weigh Stakeholder Views On Accepting EU Certificates
UK MHRA updates timings for key elements of the new system of medtech regulation in Great Britain and prepares to assess IVD sector views.
More from United Kingdom
More from Policy & Regulation
• By
The IVD industry’s new 10-point plan for healthcare change shows that medtechs will keep calling the German government to account. Tariffs, sector resilience, digital functionality are among the pressing issues industry wants answers to.
• By
The General Services Administration’s updated list of “assets identified for accelerated disposition” does not include any buildings at the agency’s headquarters in White Oak, MD after its original list of “non-core” government properties for disposal had more than half the buildings on campus.
• By
Exer Labs Inc.’s website marketed its AI-based Exer Scan app to “screen and treat Parkinson’s, TB, Cerebral Palsy and more.” But those claims went well beyond what was allowed under the product’s 510(k) clearance, US regulators say.